Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 11 | $3,050,229 |
Sells | 19 | $451,672 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 May 2022 18:19 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 18 May 2022 | Purchase | 211,268 | 3.3477 | 707,262 | I |
18 May 2022 18:19 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 17 May 2022 | Purchase | 3,440 | 3.1838 | 10,952 | I |
18 May 2022 18:19 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 16 May 2022 | Purchase | 135,292 | 3.1003 | 419,446 | I |
23 May 2022 17:49 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 23 May 2022 | Purchase | 15,599 | 3.3494 | 52,247 | I |
23 May 2022 17:49 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 20 May 2022 | Purchase | 100,000 | 3.4557 | 345,570 | I |
23 May 2022 17:49 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 19 May 2022 | Purchase | 100,000 | 3.4862 | 348,620 | I |
26 May 2022 18:02 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 26 May 2022 | Purchase | 75,000 | 3.1859 | 238,942 | I |
26 May 2022 18:02 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 25 May 2022 | Purchase | 90,155 | 3.175 | 286,242 | I |
26 May 2022 18:02 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 24 May 2022 | Purchase | 100,000 | 3.2899 | 328,990 | I |
02 Jun 2022 18:17 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 02 Jun 2022 | Purchase | 14,760 | 3.1966 | 47,182 | I |
02 Jun 2022 18:17 | MRSN | Mersana Therapeutics Inc | HACK ANDREW A. F. | Director | 31 May 2022 | Purchase | 80,759 | 3.2786 | 264,776 | I |
18 Aug 2022 16:40 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | Chief Manufacturing Officer | 17 Aug 2022 | Sale | 1,879 | 7.1 | 13,341 | D |
02 Dec 2022 16:01 | MRSN | Mersana Therapeutics Inc | YANG ARVIN | Chief Medical Officer | 01 Dec 2022 | Sale | 5,527 | 6.59 | 36,423 | D |
18 Jan 2023 20:09 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 17 Jan 2023 | Sale | 782 | 5.74 | 4,489 | D |
18 Jan 2023 20:12 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, Chief Financial Officer | 17 Jan 2023 | Sale | 5,131 | 5.74 | 29,452 | D |
18 Jan 2023 20:14 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Off. | 17 Jan 2023 | Sale | 6,233 | 5.74 | 35,777 | D |
18 Jan 2023 20:18 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, CMO | 17 Jan 2023 | Sale | 458 | 5.74 | 2,629 | D |
18 Jan 2023 20:20 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Controller | 17 Jan 2023 | Sale | 3,575 | 5.74 | 20,520 | D |
18 Jan 2023 20:24 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | President & CEO | 17 Jan 2023 | Sale | 17,346 | 5.74 | 99,566 | D |
18 Jan 2023 20:29 | MRSN | Mersana Therapeutics Inc | YANG ARVIN | SVP, Chief Medical Officer | 17 Jan 2023 | Sale | 2,209 | 5.74 | 12,680 | D |
28 Apr 2023 16:15 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 27 Apr 2023 | Sale | 3,944 | 3.89 | 15,342 | D |
18 Aug 2023 16:01 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, Chief Manuf. Officer | 17 Aug 2023 | Sale | 1,908 | 1.18 | 2,251 | D |
27 Oct 2023 16:07 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 26 Oct 2023 | Sale | 1,912 | 1.13 | 2,161 | D |
17 Jan 2024 17:16 | MRSN | Mersana Therapeutics Inc | BALA MOHAN | SVP, Chief Development Officer | 16 Jan 2024 | Sale | 3,431 | 2.71 | 9,298 | D |
17 Jan 2024 17:18 | MRSN | Mersana Therapeutics Inc | DESCHUYTNER BRIAN | SVP, COO & CFO | 16 Jan 2024 | Sale | 9,327 | 2.71 | 25,276 | D |
17 Jan 2024 17:18 | MRSN | Mersana Therapeutics Inc | CARVAJAL ALEJANDRA | SVP, Chief Legal Officer | 16 Jan 2024 | Sale | 4,381 | 2.71 | 11,873 | D |
17 Jan 2024 17:19 | MRSN | Mersana Therapeutics Inc | LOWINGER TIMOTHY B | SVP, Chief Sci.&Tech. Officer | 16 Jan 2024 | Sale | 10,409 | 2.71 | 28,208 | D |
17 Jan 2024 17:20 | MRSN | Mersana Therapeutics Inc | MANDELIA ASHISH | VP, Chief Accounting Officer | 16 Jan 2024 | Sale | 5,025 | 2.71 | 13,618 | D |
17 Jan 2024 17:21 | MRSN | Mersana Therapeutics Inc | MISRA TUSHAR | SVP, Chief Manuf. Officer | 16 Jan 2024 | Sale | 3,357 | 2.71 | 9,097 | D |
17 Jan 2024 17:21 | MRSN | Mersana Therapeutics Inc | PROTOPAPAS ANNA | Director | 16 Jan 2024 | Sale | 29,399 | 2.71 | 79,671 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)